Fuqiang J. Yin

22 Shuangyong Road
Nanning, 530021, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications

Natural Products Targeting the PI3K/Akt/mTOR-Mediated Autophagy Pathway in Cancer Therapy: Recent Advances and Clinical Perspectives.

Natural Products Targeting the PI3K/Akt/mTOR-Mediated Autophagy Pathway in Cancer Therapy: Recent Advances and Clinical Perspectives.

Journal: Journal of natural products
Published: February 12, 2026

Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer.

Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer.

Journal: Current issues in molecular biology
Published: December 21, 2025

Low LAMA2 expression may affect drug resistance and prognosis in ovarian cancer via positive LGR5 coexpression.

Low LAMA2 expression may affect drug resistance and prognosis in ovarian cancer via positive LGR5 coexpression.

Journal: Translational cancer research
Published: October 09, 2025

Identification of multigene predictors of prognosis in patients with ovarian cancer.

Identification of multigene predictors of prognosis in patients with ovarian cancer.

Journal: iScience
Published: September 06, 2025

The dual role of SLC7A11 in tumor drug resistance: mechanisms, challenges, and therapeutic potential.

The dual role of SLC7A11 in tumor drug resistance: mechanisms, challenges, and therapeutic potential.

Journal: American journal of cancer research
Published: May 13, 2025

Correction to: Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.

Correction to: Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.

Journal: Functional & integrative genomics
Published: May 13, 2024

LAMC3 interference reduces drug resistance of carboplatin-resistant ovarian cancer cells.

LAMC3 interference reduces drug resistance of carboplatin-resistant ovarian cancer cells.

Journal: Scientific reports
Published: April 28, 2024

Upregulation of miRNA-450b-5p targets ACTB to affect drug resistance and prognosis of ovarian cancer via the PI3K/Akt signaling pathway.

Upregulation of miRNA-450b-5p targets ACTB to affect drug resistance and prognosis of ovarian cancer via the PI3K/Akt signaling pathway.

Journal: Translational cancer research
Published: February 24, 2024

Low expression of GOT2 promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma.

Low expression of GOT2 promotes tumor progress and predicts poor prognosis in hepatocellular carcinoma.

Journal: Biomarkers in medicine
Published: December 14, 2023

Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.

Low FHL1 expression indicates a good prognosis and drug sensitivity in ovarian cancer.

Journal: Functional & integrative genomics
Published: November 22, 2023

Identification of genes predicting chemoresistance and short survival in ovarian cancer.

Identification of genes predicting chemoresistance and short survival in ovarian cancer.

Journal: Translational cancer research
Published: November 22, 2023

Identification and verification of novel ferroptosis biomarkers predicts the prognosis of hepatocellular carcinoma.

Identification and verification of novel ferroptosis biomarkers predicts the prognosis of hepatocellular carcinoma.

Journal: Genomics
Published: May 31, 2023
Showing 1-12 of 45

Last Updated: 09/26/2026